ALMAS.PA stock down 13.21% to €0.0092 on EURONEXT 21 Jan 2026: outlook

ALMAS.PA stock down 13.21% to €0.0092 on EURONEXT 21 Jan 2026: outlook

We note ALMAS.PA stock fell 13.21% to €0.0092 on EURONEXT at market close on 21 Jan 2026, making it one of today’s top losers. Trading volume hit 347,103 shares, above the average of 602,872, and the intraday range sat between €0.0092 and €0.0098. The drop follows weak financial metrics and negative momentum in small-cap Consumer Defensive names. We examine financial ratios, technicals and Meyka AI model forecasts to separate short-term noise from longer-term valuation questions for Mastrad SA (ALMAS.PA).

ALMAS.PA stock: price action and market context

ALMAS.PA stock closed at €0.0092, down €0.0014 from yesterday and off 13.21% for the day. Market cap stands at €721,280 and shares outstanding are 78,400,000. The company trades on EURONEXT in Europe and sits near its year low of €0.0076 versus a year high of €0.0488. Sector peers in Consumer Defensive showed modest moves, leaving Mastrad notably weak among small-cap household-product names. For the latest peer comparison see Investing.com source.

Financials, valuation and key metrics — ALMAS.PA analysis

Mastrad reports trailing EPS of -0.02 and a negative P/E of -0.46, reflecting losses. Price-to-book is low at 0.53, while price-to-sales is 1.48. Working capital is €383,000 and tangible assets are €1,269,000, giving book value per share €0.01732. Cash per share is €0.00291, and debt-to-equity is 0.93. These figures show thin liquidity and negative margins, consistent with a small-cap turnaround profile. Investors should weigh the low PB against weak profitability and a long cash-conversion cycle (cash conversion cycle 164 days).

Technical picture and trading flow — ALMAS.PA trading

Technicals show mixed short-term momentum. RSI sits near 52.32, ADX at 22.22 suggests a developing trend, and the 50-day average equals €0.009192. Average volume (50-day) is 602,872, while today’s 347,103 implies elevated but not extreme interest. The stock has delivered a -35.21% 6-month move and a 6.98% YTD rise; intraday sellers pushed price to the session low €0.0092. For traders, the key levels are year low €0.0076 and near-term resistance €0.01.

Meyka AI grade and model forecast — ALMAS.PA rating and forecast

Meyka AI rates ALMAS.PA with a score out of 100: 62.20 / 100 — Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly €0.03, quarterly €0.02, and yearly €0.005994. Compared with the current price €0.0092, monthly projection implies +226.09% upside, quarterly implies +117.39%, and the yearly view implies -34.84% downside. Forecasts are model-based projections and not guarantees. See Mastrad’s site for corporate details source.

Analyst view and realistic price targets — ALMAS.PA price target

Given current liquidity and margin pressure, a conservative trader price target range is €0.0050 to €0.03. A near-term downside target of €0.0050 reflects weak profitability and low cash reserves. An upside scenario to €0.03 requires clear margin recovery or a deal-driven re-rating. Our framing follows sector valuation: Consumer Defensive peers trade at PB near 2.06 and P/E around 24.35, highlighting Mastrad’s small-cap discount but also execution risk.

Risks and catalysts for investors — ALMAS.PA risks and opportunities

Key risks include continued negative EPS, tight cash per share (€0.00291), long receivables cycle (DSO 313 days), and limited analyst coverage. Catalysts would be a visible margin recovery, cost cuts, or a strategic partnership in Europe or export markets. Liquidity risk is elevated given average volume and market cap under €1m; institutional interest is unlikely until fundamentals improve.

Final Thoughts

ALMAS.PA stock closed the session as a top loser on EURONEXT on 21 Jan 2026, dropping to €0.0092 on 13.21% weaker trading and 347,103 shares changing hands. Financials show negative EPS (-0.02), a negative P/E, and a low PB of 0.53, which explains the steep discount but also signals real operational strain. Meyka AI’s forecast model projects a split view: short-term upside scenarios (monthly €0.03, quarterly €0.02) but a modest one-year downside (€0.005994), producing both opportunity and risk. Meyka AI rates ALMAS.PA 62.20 / 100 (B, HOLD) reflecting mixed signals between valuation and financial stress. Traders should treat the stock as speculative: downside risk to €0.0050 if margins worsen, or relief rallies toward €0.02–€0.03 if sales and cash conversion improve. We use Meyka AI’s real-time signals and model projections to flag catalysts and stop levels, not as investment advice. Monitor quarterly updates, cash flow trends, and any strategic announcements before increasing exposure.

FAQs

Why did ALMAS.PA stock fall sharply today?

The slide to €0.0092 reflects weak fundamentals, negative EPS (-0.02), and thin liquidity. Elevated selling pressure and long receivables (DSO 313 days) amplified the decline. No single news release explains the move; structural valuation and trading flow drove the drop.

What is Meyka AI’s view on ALMAS.PA forecast?

Meyka AI’s forecast model projects monthly €0.03, quarterly €0.02, and yearly €0.005994. These imply asymmetric scenarios: large short-term upside if execution improves, or a one-year downside if margins and cash flow stay weak.

What price targets should investors consider for ALMAS.PA stock?

A realistic short-term target band is €0.02–€0.03 in a recovery, and a downside risk to €0.0050 if conditions deteriorate. Targets depend on margin recovery, cash flow and any strategic deals.

Is ALMAS.PA a buy, hold or sell now?

Meyka AI assigns ALMAS.PA a B grade (62.20) with a suggestion to HOLD due to valuation discount but clear operational risks. This is informational, not investment advice; perform your own due diligence.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *